Evidence map›Paper›PMID 31741718›Full record

ArticleOncotarget2019

Correction: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.

Xinxing Li, Shifeng Teng, Yanyan Zhang, Weigang Zhang, Xianwen Zhang, Kai Xu, Houshan Yao, Jun Yao, Haolu Wang, Xiaowen Liang and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Xinxing Li *Department of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.
Shifeng Teng *Department of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.
Yanyan Zhang *Department of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.
Weigang ZhangDepartment of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.
Xianwen ZhangDepartment of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.
Kai XuDepartment of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.
Houshan YaoDepartment of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.
Jun YaoDepartment of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.
Haolu WangTherapeutics Research Centre, School of Medicine, The University of Queensland, Princess Alexandra Hospital, Woolloongabba QLD 4102, Australia.
Xiaowen LiangTherapeutics Research Centre, School of Medicine, The University of Queensland, Princess Alexandra Hospital, Woolloongabba QLD 4102, Australia.
Zhiqian HuDepartment of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.16789.].

Identifiers

PMID31741718
PMCPMC6849646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.